Journal Home > Volume 3 , Issue 3-4

Bone morphogenetic proteins (BMPs) are a family of potent, multifunctional growth factors belonging to transforming growth factor-β (TGF-β). They are highly conservative in structures. Over 20 members of BMPs with varying functions such as embryogenesis, skeletal formation, hematopoiesis and neurogenesis have been identified in human body. BMPs are unique growth factors that can induce the formation of bone tissue individually. BMPs can induce the differentiation of bone marrow mesenchymal stem cells into osteoblastic lineage and promote the proliferation of osteoblasts and chondrocytes. BMPs stimulate the target cells by specific membrane-bound receptors and signal transduced through mothers against decapentaplegic (Smads) and mitogen activated protein kinase (MAPK) pathways. It has been demonstrated that BMP-2, BMP-4, BMP-6, BMP-7, and BMP-9 play an important role in bone formation. This article focuses on the molecular characterization of BMPs family members, mechanism of osteogenesis promotion, related signal pathways of osteogenic function, relationships between structure and osteogenetic activity, and the interactions among family members at bone formation.


menu
Abstract
Full text
Outline
About this article

Bone morphogenetic proteins: Relationship between molecular structure and their osteogenic activity

Show Author's information Jian YangPujie ShiMaolin TuYun WangMeng LiuFengjiao FanMing Du( )
School of Food Science and Engineering, Harbin Institute of Technology, Harbin 150090, PR China

Peer review under responsibility of Beijing Academy of Food Sciences.

Abstract

Bone morphogenetic proteins (BMPs) are a family of potent, multifunctional growth factors belonging to transforming growth factor-β (TGF-β). They are highly conservative in structures. Over 20 members of BMPs with varying functions such as embryogenesis, skeletal formation, hematopoiesis and neurogenesis have been identified in human body. BMPs are unique growth factors that can induce the formation of bone tissue individually. BMPs can induce the differentiation of bone marrow mesenchymal stem cells into osteoblastic lineage and promote the proliferation of osteoblasts and chondrocytes. BMPs stimulate the target cells by specific membrane-bound receptors and signal transduced through mothers against decapentaplegic (Smads) and mitogen activated protein kinase (MAPK) pathways. It has been demonstrated that BMP-2, BMP-4, BMP-6, BMP-7, and BMP-9 play an important role in bone formation. This article focuses on the molecular characterization of BMPs family members, mechanism of osteogenesis promotion, related signal pathways of osteogenic function, relationships between structure and osteogenetic activity, and the interactions among family members at bone formation.

Keywords: Interaction, Structure, Bone morphogenetic proteins, Osteogenic activity, Signal pathways

References(73)

[1]

M.R. Urist, Bone: formation by autoinduction, Science 150 (3698) (1965) 893–899.

[2]

M.F. Termaat, F.C. Den Boer, F.C. Bakker, et al., Bone morphogenetic proteins development and clinical efficacy in the treatment of fractures and bone defects, J. Bone Joint Surg. 87 (6) (2005) 1367–1378.

[3]

Y. Shi, J. Massagué, Mechanisms of TGF-β signaling from cell membrane to the nucleus, Cell 113 (6) (2003) 685–700.

[4]

K. Miyazono, S. Maeda, T. Imamura, Bmp receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk, Cytokine Growth Factor Rev. 16 (3) (2005) 251–263.

[5]

Y. Xiao, L. Xiang, J. Shao, Bone morphogenetic protein, Biochem. Biophys. Res. Commun. 362 (3) (2007) 550–553.

[6]

S.M. Nelsen, J.L. Christian, Site-specific cleavage of BMP4 by furin, PC6, and PC7, J. Biol. Chem. 284 (40) (2009) 27157–27166.

[7]

A. Nohe, E. Keating, P. Knaus, et al., Signal transduction of bone morphogenetic protein receptors, Cell. Signal. 16 (3) (2004) 291–299.

[8]

S.C. Little, M.C. Mullins, Bone morphogenetic protein heterodimers assemble heteromeric type Ⅰ receptor complexes to pattern the dorsoventral axis, Nat. Cell Biol. 11 (5) (2009) 637–643.

[9]

D.I. Israel, J. Nove, K.M. Kerns, et al., Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo, Growth Factors 13 (3/4) (1996) 291–300.

[10]

H. Seeherman, J.M. Wozney, Delivery of bone morphogenetic proteins for orthopedic tissue regeneration, Cytokine Growth Factor Rev. 16 (3) (2005) 329–345.

[11]

Q. Kang, M.H. Sun, H. Cheng, et al., Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery, Gene Ther. 11 (17) (2004) 1312–1320.

[12]

A. Nohe, S. Hassel, M. Ehrlich, et al., The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways, J. Biol. Chem. 277 (7) (2002) 5330–5338.

[13]

R. Nishimura, K. Hata, F. Ikeda, et al., The role of Smads in BMP signaling, Front. Biosci. 8 (2003) s275–s284.

[14]

V. Rosen, BMP2 signaling in bone development and repair, Cytokine Growth Factor Rev. 20 (5) (2009) 475–480.

[15]

S. Akiyoshi, H. Inoue, J. Hanai, et al., C-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads, J. Biol. Chem. 274 (49) (1999) 35269–35277.

[16]

L. Chen, Insulin-like Growth Factor 1(IGF-1) Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells and Bone Formation, D. Chong Qing Medical University, 2010, pp. 10–12.

[17]

C. Scheufler, W. Sebald, M. Hülsmeyer, Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution, J. Mol. Biol. 287 (1) (1999) 103–115.

[18]

G. Pan, J. Wen, G. Pan, Progress in bone morphogenetic proteins-2, Chin. J. Tradit. Med. Traumatol. Orthop. 14 (6) (2007) 78–80.

[19]

M. Bais, N. Wigner, M. Young, et al., BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells, Bone 45 (2) (2009) 254–266.

[20]

T. Yin, L. Li, The stem cell niches in bone, J. Clin. Investig. 116 (5) (2006) 1195–1201.

[21]

D. Chen, M. Harris, G. Rossini, et al., Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts, Calcif. Tissue Int. 60 (3) (1997) 283–290.

[22]

T. Matsubara, K. Kida, A. Yamaguchi, et al., BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation, J. Biol. Chem. 283 (43) (2008) 29119–29125.

[23]

K. Tsuji, A. Bandyopadhyay, B.D. Harfe, et al., BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing, Nat. Genet. 38 (12) (2006) 1424–1429.

[24]

K. Tsuji, K. Cox, L. Gamer, et al., Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair, J. Orthop. Res. 28 (3) (2010) 384–389.

[25]

F. Kaplan, D. Glaser, F. Gannon, et al., The molecules of immobility: searching for the skeleton key, Univ. Pa. Orthop. J. 11 (1998) 59–66.

[26]

E. Shore, M. Xu, P. Shah, et al., The human bone morphogenetic protein 4 (BMP-4) gene: molecular structure and transcriptional regulation, Calcif. Tissue Int. 63 (3) (1998) 221–229.

[27]

G. Li, Y. Hou, G. Yang, et al., Cloning and sequencing determination of bone morphogenetic protein-4 cDNA, Chin. J. Cell. Mol. Immunol. 18 (2) (2002) 186–187.

[28]

H. Mao, The biological function of BMP-4 and its application in the field of sport injury, J. Yichun Coll. 31 (2) (2009) 145–147.

[29]

H. Zhang, Y. Chen, S. Yu, Progress in bone morphogenetic proteins-4, Chin. J. Anat. 30 (6) (2008) 810–813.

[30]

H. Yaoita, H. Orimo, Y. Shirai, et al., Expression of bone morphogenetic proteins and rat distal-less homolog genes following rat femoral fracture, J. Bone Miner. Metab. 18 (2) (2000) 63–70.

[31]

V.J. Wright, H. Peng, A. Usas, et al., BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice, Mol. Ther. 6 (2) (2002) 169–178.

[32]

T. Nakase, S. Nomura, H. Yoshikawa, et al., Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing, J. Bone Miner. Res. 9 (5) (1994) 651–659.

[33]

M. Tazoe, M. Mogi, S. Goto, et al., Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells, Arch. Oral Biol. 48 (8) (2003) 615–619.

[34]

H. Peng, V. Wright, A. Usas, et al., Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4, J. Clin. Investig. 110 (6) (2002) 751–759.

[35]

I. Sekiya, D.C. Colter, D.J. Prockop, BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells, Biochem. Biophys. Res. Commun. 284 (2) (2001) 411–418.

[36]

G.P. Allendorph, M.J. Isaacs, Y. Kawakami, et al., BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors, Biochemistry 46 (43) (2007) 12238–12247.

[37]

T. Ebisawa, K. Tada, I. Kitajima, et al., Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation, J. Cell Sci. 112 (20) (1999) 3519–3527.

[38]

S. Saremba, J. Nickel, A. Seher, et al., Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand, FEBS J. 275 (1) (2008) 172–183.

[39]

O. Mizrahi, D. Sheyn, W. Tawackoli, et al., BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells, Gene Ther. 20 (4) (2012) 370–377.

[40]

T.A. Zachos, K.M. Shields, A.L. Bertone, Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6, J. Orthop. Res. 24 (6) (2006) 1279–1291.

[41]

F. Zhu, M.S. Friedman, W. Luo, et al., The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation, J. Cell. Physiol. 227 (6) (2012) 2677–2685.

[42]

L.C.C. Yeh, A.D. Tsai, J.C. Lee, Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12, J. Cell. Biochem. 87 (3) (2002) 292–304.

[43]

Y. Shen, X. Li, W. Wang, Application of bone morphogenetic protein 7 in the orthopedics, J. Clin. Rehabil. Tissue Eng. Res. 15 (26) (2011) 4864–4867.

[44]

W.D. Fairlie, H. Zhang, W. Wu, et al., The propeptide of the transforming growth factor-B superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion, J. Biol. Chem. 276 (20) (2001) 16911–16918.

[45]

D.L. Griffith, P.C. Keck, T.K. Sampath, et al., Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily, Proc. Natl. Acad. Sci. U. S. A. 93 (2) (1996) 878–883.

[46]

G. Wang, S. Wang, J. Han, Progress in bone morphogenetic proteins-7, J. Med. Mol. Biol. 1 (6) (2005) 382–385.

[47]

Y. Chen, Y. Zhang, Current studies of bone morphogenetic protein's osteoinductivity and its use, Chin. Rem. Clin. 3 (4) (2003) 277–280.

[48]

B. Shen, A. Wei, S. Whittaker, et al., The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro, J. Cell. Biochem. 109 (2) (2010) 406–416.

[49]

C. Miyamoto, T. Matsumoto, K. Sakimura, et al., Osteogenic protein-1 with transforming growth factor-β1: potent inducer of chondrogenesis of synovial mesenchymal stem cells in vitro, J. Orthop. Sci. 12 (6) (2007) 555–561.

[50]

A.C. Varga, J.L. Wrana, The disparate role of BMP in stem cell biology, Oncogene 24 (37) (2005) 5713–5721.

[51]

H. Cheng, W. Jiang, F.M. Phillips, et al., Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs), J. Bone Joint Surg. 85 (8) (2003) 1544–1552.

[52]

D. Sheyn, N. Kimelman-Bleich, G. Pelled, et al., Ultrasound-based nonviral gene delivery induces bone formation in vivo, Gene Ther. 15 (4) (2007) 257–266.

[53]

H. Aslan, Y. Zilberman, V. Arbeli, et al., Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration, Tissue Eng. 12 (4) (2006) 877–889.

[54]

G. Luther, R. Wagner, E.G. Zhu, et al., BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential, Curr. Gene Ther. 11 (3) (2011) 229–240.

[55]

D. Xu, J. Wang, Y.G. Weng, Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1,2 mesenchymal stem cells, Biochem. Mol. Biol. Rep. 45 (4) (2012) 247–252.

[56]

Y. Wang, S. Hong, M. Li, et al., Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells, J. Orthop. Res. 31 (11) (2013) 1796–1803.

[57]

M. Kessler, J. Steinz, M. Anderegg, et al., The infrared space observatory (ISO) mission, Astron. Astrophys. 315 (1996) L27–L31.

[58]

D.R. Hopkins, S. Keles, D.S. Greenspan, The bone morphogenetic protein 1/tolloid-like metalloproteinases, Matrix Biol. 26 (7) (2007) 508–523.

[59]

A. Mac Sweeney, S. Gil-Parrado, D. Vinzenz, et al., Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases, J. Mol. Biol. 384 (1) (2008) 228–239.

[60]

G. Ge, D.S. Greenspan, Developmental roles of the BMP1/TLD metalloproteinases, Birth Defects Res. C: Embryo Today 78 (1) (2006) 47–68.

[61]

L. Grgurevic, B. Macek, M. Mercep, et al., Bone morphogenetic protein (BMP) 1–3 enhances bone repair, Biochem. Biophys. Res. Commun. 408 (1) (2011) 25–31.

[62]

A. Daluiski, T. Engstrand, M.E. Bahamonde, et al., Bone morphogenetic protein-3 is a negative regulator of bone density, Nat. Genet. 27 (1) (2001) 84–88.

[63]

R.P. Nacamuli, K.D. Fong, K.A. Lenton, et al., Expression and possible mechanisms of regulation of BMP3 in rat cranial sutures, Plast. Reconstr. Surg. 116 (5) (2005) 1353–1362.

[64]

L.W. Gamer, J. Nove, M. Levin, et al., BMP-3 is a novel inhibitor of both activin and BMP-4 signaling in xenopus embryos, Dev. Biol. 285 (1) (2005) 156–168.

[65]

M.E. Bahamonde, K.M. Lyons, BMP3: to be or not to be a BMP, J. Bone Joint Surg. 83 (Suppl. 1, Part 1) (2001) S56–S62.

[66]

A. Stewart, H. Guan, K. Yang, BMP-3 promotes mesenchymal stem cell proliferation through the TGF-β/activin signaling pathway, J. Cell. Physiol. 223 (3) (2010) 658–666.

[67]

K. Uenishi, H. Ishida, Y. Toba, et al., Milk basic protein increases bone mineral density and improves bone metabolism in healthy young women, Osteoporos. Int. 18 (2007) 385–390.

[68]

Y. Morita, H. Matsuyama, A. Serizawa, et al., Identification of angiogenin as the osteoclastic bone resorption-inhibitory factor in bovine milk, Bone 42 (2008) 380–387.

[69]

N. Azuma, A. Maeta, K. Fukuchi, et al., A rapid method for purifying osteopontin from bovine milk and interaction between osteopontin and other milk proteins, Int. Dairy J. 16 (2006) 370–378.

[70]

M.A. Chellaiah, N. Kizer, R. Biswas, et al., Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression, Mol. Biol. Cell 14 (1) (2003) 173–189.

[71]

Y. Koyama, S.R. Rittling, K. Tsuji, et al., Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts, Endocrinology 147 (6) (2006) 3004–3009.

[72]

T. Kendall, L. Mukai, A.L. Jannuzi, et al., Identification of integrin β subunit mutations that alter affinity for extracellular matrix ligand, J. Biol. Chem. 286 (35) (2011) 30981–30993.

[73]

E. Feyfant, A. Sali, A. Fiser, Modeling mutations in protein structures, Protein Sci. 16 (9) (2007) 2030–2041.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 05 December 2014
Accepted: 26 December 2014
Published: 05 January 2015
Issue date: December 2014

Copyright

© 2015 Beijing Academy of Food Sciences.

Acknowledgements

Acknowledgements

This work was supported by National Natural Science Foundation Funding (31101316; 31371805), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-11-0796) and Heilongjiang Province Postdoctoral Science Foundation.

Rights and permissions

Return